CDKN1A and Alzheimer disease: Prior studies [41, 45] have reported that microglial senescence is more prevalent in AD than in non-diseased brains, supported by increased immunostaining of senescence markers such as β-galactosidase, p16, p21 [46], and γH2AX [47].